Evidence map›Paper›PMID 36333837›Full record

ArticleJournal of medical virology2023

Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.

Jorge Camacho, Estela Giménez, Eliseo Albert, Joao Zulaica, Beatriz Álvarez-Rodríguez, Ignacio Torres, Luciana Rusu, Javier S Burgos, Salvador Peiró, Hermelinda Vanaclocha and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave.International journal of environmental research and public health · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Jorge CamachoMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID 0000-0002-6602-0966
Estela GiménezMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Eliseo AlbertMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Joao ZulaicaInstitute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
Beatriz Álvarez-RodríguezInstitute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
Ignacio TorresMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Luciana RusuInstitute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
Javier S BurgosGeneral Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain.
Salvador PeiróFoundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
Hermelinda VanaclochaGeneral Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
Ramón LimónGeneral Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain.
María Jesús AlcarazMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
José Sánchez-PayáPreventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.
Javier Díez-DomingoFoundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
Iñaki ComasBiomedicine Institute of Valencia, Spanish Research Council (CSIC), Valencia, Spain.
Fernando Gonzáles-CandelasInstitute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.ORCID 0000-0002-0879-5798
Ron GellerInstitute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
David NavarroMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID 0000-0003-3010-4110
Valencian Vaccine Research Program (ProVaVac) study group
Universitat de València · ESINCLIVA Health Research Institute · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESGeneralitat Valenciana · ESGovernment of Spain · ESHospital General Universitario de Alicante Doctor Balmis · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies investigating the cumulative incidence of and immune status against SARS-CoV-2 infection provide valuable information for shaping public health decision-making. A cross-sectional study on 935 participants, conducted in the Valencian Community (VC), measuring anti-SARS-CoV-2-receptor binding domain-RBD-total antibodies and anti-Nucleocapsid (N)-IgGs via electrochemiluminescence assays. Quantitation of neutralizing antibodies (NtAb) against ancestral and Omicron BA.1 and BA.2 variants and enumeration of SARS-CoV-2-S specific-IFNγ-producing CD4

Indexed as

COVID-19Antibodies, NeutralizingAntibodies, ViralCD8-Positive T-LymphocytesCross-Sectional StudiesHumansIncidenceSARS-CoV-2SpainAntibodies, NeutralizingAntibodies, Viralcumulative incidence of SARS-CoV-2 infectionneutralizing antibodiesSARS-CoV-2seroprevalenceT cells

Identifiers

PMID36333837
PMCPMC9828341
OpenAlexW4308255861

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.